سعر فلاموجين 30 قرص 2024

Gastro-resistant (enteric-coated) tablets combining the proteolytic enzymes bromelain 90 mg and trypsin 48 mg with rutoside 100 mg; anti-inflammatory/anti-oedema enzyme preparation.

• Adjunctive treatment in adults of post-traumatic and post-operative oedema.Population: AdultsMUCOS Pharma GmbH & Co. KG (SPC published via Nestlé Health Science Czech Republic)
• Adjunctive treatment in adults of inflammatory conditions, e.g. of the urogenital and venous systems.Population: AdultsMUCOS Pharma GmbH & Co. KG (SPC published via Nestlé Health Science Czech Republic)
• Adjunctive treatment in adults of inflammatory rheumatic diseases: rheumatoid arthritis, soft-tissue rheumatism and inflammatory activation of degenerative joint and spine disease.Population: AdultsMUCOS Pharma GmbH & Co. KG (SPC published via Nestlé Health Science Czech Republic)

• Most frequently associated with gastrointestinal adverse reactions and hypersensitivity manifestations, mostly non-serious and resolving on stopping treatment; temporary changes in stool consistency, colour and odour have been observed.International label, same formulation · MUCOS Pharma GmbH & Co. KG (SPC published via Nestlé Health Science Czech Republic)

• Hypersensitivity to the active substances or to any excipient.International label, same formulation · MUCOS Pharma GmbH & Co. KG (SPC published via Nestlé Health Science Czech Republic)
• Severe congenital or acquired blood coagulation disorders (e.g. haemophilia, severe liver damage, dialysis patients).International label, same formulation · MUCOS Pharma GmbH & Co. KG (SPC published via Nestlé Health Science Czech Republic)

• In chronic diseases symptoms may worsen after the start of treatment; do not stop, but consider a temporary dose reduction.International label, same formulation · MUCOS Pharma GmbH & Co. KG (SPC published via Nestlé Health Science Czech Republic)
• The mild fibrinolytic effect must be taken into account before surgery.International label, same formulation · MUCOS Pharma GmbH & Co. KG (SPC published via Nestlé Health Science Czech Republic)
• Does not replace antibiotic treatment of infectious inflammation.International label, same formulation · MUCOS Pharma GmbH & Co. KG (SPC published via Nestlé Health Science Czech Republic)

• Antibiotics and chemotherapeutic agentsNo adverse interactions are known; there are reports of increased blood levels of some antibiotics and chemotherapeutic agents when given together.MUCOS Pharma GmbH & Co. KG (SPC published via Nestlé Health Science Czech Republic)

• Data in pregnant women are limited or unavailable; use during pregnancy is not recommended.International label, same formulation · MUCOS Pharma GmbH & Co. KG (SPC published via Nestlé Health Science Czech Republic)
• Information on excretion in breast milk is insufficient and a risk to the infant cannot be excluded; decide whether to stop breastfeeding or the treatment.International label, same formulation · MUCOS Pharma GmbH & Co. KG (SPC published via Nestlé Health Science Czech Republic)

English text not available for this section.